Straumann Holding AG:市場シェア分析...市場調査レポートについてご紹介

【英文タイトル】Straumann Holding AG Market Share Analysis

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 12
2.1 What Is This Report About? 12
3 Definitions of Markets/Categories Covered 13
3.1 Dental Devices 13
3.1.1 CAD/CAM Dental Systems 13
3.1.2 Dental Biomaterials 13
3.1.3 Dental Implants 13
4 Company Snapshot 14
4.1 Key Facts 14
4.2 Company Overview 14
4.3 Financial Performance 14
4.4 SWOT Snapshot 14
5 Business Description 15
5.1 Business Overview 15
5.2 Prosthetics Unit 15
5.2.1 Overview 15
5.2.2 Market View 15
5.3 Regenerative Unit 15
5.3.1 Overview 15
5.3.2 Market View 15
5.4 Surgical Unit 16
5.4.1 Overview 16
5.4.2 Market View 16
5.5 Major Products and Services 16
5.5.1 Overview 16
6 History 18
7 SWOT Analysis 21
7.1 Overview 21
7.2 Straumann Holding AG Strengths 21
7.2.1 Product Development Capabilities 21
7.2.2 Strong Liquidity Position 22
7.2.3 Leading Market Position 22
7.2.4 Awards and Recognitions 22
7.3 Straumann Holding AG Weaknesses 22
7.3.1 Product Recalls 22
7.3.2 Declining Profitability 23
7.4 Straumann Holding AG Opportunities 23
7.4.1 Growing Dental Devices Market 23
7.4.2 Growing Aged Population 23
7.4.3 Perpetual Innovation 24
7.4.4 Inorganic Growth Strategy 24
7.5 Straumann Holding AG Threats 24
7.5.1 Uncertain R&D Outcomes 24
7.5.2 Stringent Government Regulations 24
7.5.3 Competitive Landscape 25
7.5.4 Rapid Technological Change 25
8 Competitors 26
9 Competitive Landscape 27
9.1 Dental Devices (Dental Implants), Global, Market Share (%), 2011 27
9.2 Straumann Holding AG, Dental Devices (Dental Implants), by Region, Market Share (2011) 29
9.3 Straumann Holding AG, Dental Devices (Dental Implants), by Country, Market Share (2011) 30
9.4 Dental Devices (CAD/CAM Dental Systems), Global, Market Share (%), 2011 32
9.5 Straumann Holding AG, Dental Devices (CAD/CAM Dental Systems), by Region, Market Share (2011) 33
9.6 Straumann Holding AG, Dental Devices (CAD/CAM Dental Systems), by Country, Market Share (2011) 34
9.7 Dental Devices (Dental Biomaterials), Global, Market Share (%), 2011 36
9.8 Straumann Holding AG, Dental Devices (Dental Biomaterials), by Region, Market Share (2011) 37
9.9 Straumann Holding AG, Dental Devices (Dental Biomaterials), by Country, Market Share (2011) 38
9.10 Straumann Holding AG, Dental Devices, Global, Category Revenue Share (2011) 40
9.11 Straumann Holding AG, Asia-Pacific, Category Revenue Share (2011) 42
9.11.1 Straumann Holding AG, Australia, Category Revenue Share (2011) 44
9.11.2 Straumann Holding AG, China, Category Revenue Share (2011) 46
9.11.3 Straumann Holding AG, India, Category Revenue Share (2011) 48
9.11.4 Straumann Holding AG, Japan, Category Revenue Share (2011) 49
9.11.5 Straumann Holding AG, Other Asia-Pacific, Category Revenue Share (2011) 51
9.12 Straumann Holding AG, Europe, Category Revenue Share (2011) 53
9.12.1 Straumann Holding AG, France, Category Revenue Share (2011) 55
9.12.2 Straumann Holding AG, Germany, Category Revenue Share (2011) 57
9.12.3 Straumann Holding AG, Italy, Category Revenue Share (2011) 59
9.12.4 Straumann Holding AG, Spain, Category Revenue Share (2011) 61
9.12.5 Straumann Holding AG, United Kingdom, Category Revenue Share (2011) 63
9.12.6 Straumann Holding AG, Other Europe, Category Revenue Share (2011) 65
9.13 Straumann Holding AG, Middle East and Africa, Category Revenue Share (2011) 67
9.14 Straumann Holding AG, North America, Category Revenue Share (2011) 69
9.14.1 Straumann Holding AG, Canada, Category Revenue Share (2011) 71
9.14.2 Straumann Holding AG, United States, Category Revenue Share (2011) 73
9.15 Straumann Holding AG, South and Central America, Category Revenue Share (2011) 75
9.15.1 Straumann Holding AG, Brazil, Category Revenue Share (2011) 77
9.15.2 Straumann Holding AG, Other South and Central America, Category Revenue Share (2011) 79
10 Key Employees 81
10.1 Key Employee Biographies 82
11 Company Statement 83
12 Locations And Subsidiaries 88
12.1 Head Office 88
12.2 Other Locations & Subsidiaries 88
13 Financial Deals Landscape 92
13.1 Straumann Holding AG, Deals Volume Summary, 2007 to YTD 2013 92
14 Straumann Holding AG, Deals Summary By Region, 2007 to YTD 2013 93
15 Straumann Holding AG Detailed Deal Summary 95
15.1 Partnerships 95
15.1.1 Dental Wings, 3M ESPE Enters Into Agreement With Straumann 95
15.1.2 Straumann Holding Signs North American Distribution Agreement With Cadent 96
15.1.3 Straumann Holding Enters Into Distribution Agreement With Cadent 97
15.2 Acquisition 98
15.2.1 GIC Acquires 10% Stake In Straumann 98
15.2.2 Straumann Acquires 49% Stake In Neodent, Dental Implant Company, For $277.3 Million 100
15.2.3 Straumann Acquires 30% Stake In Dental Wings 102
15.2.4 Straumann Acquires Ormedent spol 103
15.2.5 Straumann Holding Acquires 100% Interest In B.I. Trading 104
15.2.6 Straumann Acquires Daishin Implant System 105
15.2.7 Straumann Holding Acquires Etkon 106
16 Recent Developments 107
16.1 Strategy And Business Planning 107
16.1.1 Dec 05, 2011: Straumann To Implement New Organizational Structure In 2012 107
16.1.2 Mar 23, 2009: Straumann And Ivoclar Vivadent Announce Partnership 108
16.1.3 Jan 04, 2008: Straumann Opens Office In Budapest 108
16.2 Financial Announcements 108
16.2.1 Oct 30, 2012: Straumann Reports Revenue Of CHF156.8m For Nine Months Ended September 30, 2012 108
16.2.2 Aug 21, 2012: Straumann Reports Revenue Of CHF361.7m In H1 2012 110
16.2.3 Apr 26, 2012: Straumann Reports Group Revenue Of CHF185.1m In Q1 2012 111
16.2.4 Feb 22, 2012: Straumann Reports Revenue Of CHF693.6m In 2011 112
16.2.5 Oct 25, 2011: Straumann Reports Group Revenue Of CHF518m For Nine Months Ended September 30, 2011 114
16.2.6 Aug 16, 2011: Straumann Reports Profit Of CHF38.5m In H1 2011 114
16.2.7 Apr 27, 2011: Straumann Reports Group Net Revenue Of CHF188.4m In Q1 2011 115
16.2.8 Feb 15, 2011: Straumann Reports Profit Of CHF131.1m In 2010 115
16.2.9 Oct 28, 2010: Straumann Reports Group Net Revenue Of CHF161.6 Million For Q3 2010 116
16.2.10 Aug 19, 2010: Straumann Reports Profit Of CHF82 Million In H1 2010 117
16.2.11 Apr 27, 2010: Straumann Reports Net Revenues Of CHF199.2 Million In Q1 2010 118
16.2.12 Feb 16, 2010: Straumann Reports Profit Of CHF146.4 Million In 2009 119
16.2.13 Oct 29, 2009: Straumann Reports Group Net Revenue Of CHF168.2 Million In Q3 2009 121
16.2.14 Aug 11, 2009: Straumann Reports Profit Of CHF84.6 Million In H1 2009 123
16.2.15 Apr 28, 2009: Straumann Reports Group Revenue Of CHF196.4 Million In Q1 2009 125
16.2.16 Jan 16, 2009: Straumann Declares 2008 Results 126
16.2.17 Oct 30, 2008: Straumann Reports 3Q 2008 Results 127
16.2.18 Aug 07, 2008: Straumann Reports 1H 2008 Results 129
16.2.19 Apr 28, 2008: Straumann Reports Q1 2008 Results 131
16.2.20 Apr 01, 2008: Straumann Declares Annual Dividend 133
16.2.21 Feb 07, 2008: Straumann Declares 2007 Results 133
16.2.22 Nov 02, 2007: Straumann Declares Q3 2007 Results 135
16.2.23 Aug 08, 2007: Straumann Reports H1 2007 Results 136
16.2.24 May 03, 2007: Straumann Reports Q1 2007 Results 138
16.2.25 Mar 30, 2007: Straumann Declares 20% Increase In Dividend 139
16.2.26 Feb 07, 2007: Straumann Reports 2006 Results 139
16.2.27 Oct 25, 2006: Straumann Reports Q3 2006 Results 140
16.2.28 Aug 11, 2006: Straumann Reports H1 2006 Results 141
16.3 Corporate Communications 143
16.3.1 Jan 04, 2013: Straumann Names Marco Gadola As CEO 143
16.3.2 Oct 30, 2012: Straumann To Cut 150 Jobs 143
16.3.3 Sep 28, 2011: Straumann Appoints Andy Molnar Head Of North America 143
16.3.4 Jul 09, 2010: Straumann CFO Wolf-Rüdiger Daetz To Step Down 144
16.3.5 Mar 26, 2010: Straumann Announces Executive Changes 144
16.3.6 Nov 12, 2009: Straumann Appoints Wolf-Rudiger Daetz As CFO 145
16.3.7 Jun 19, 2008: Straumann Appoints New CFO 145
16.3.8 Mar 10, 2008: Straumann CFO Resigns 146
16.3.9 Apr 02, 2007: Straumann Re-elects Board Members 146
16.4 Legal and Regulatory 146
16.4.1 Jan 19, 2007: Straumann Receives Warning Letter From FDA For Dental Bone Grafting Products 146
16.5 Product News 147
16.5.1 Jul 02, 2012: 3M ESPE Brings Lava Ultimate Restorative To Labs 147
16.5.2 Mar 06, 2012: Straumann Launches CARES Visual 7.0 147
16.5.3 Mar 02, 2012: Straumann Standard Plus Narrow Neck CrossFit Enters Full Market Release 148
16.5.4 Oct 13, 2011: Straumann Launches Resin Nano Ceramic For Tooth Restorations 149
16.5.5 Mar 07, 2011: Straumann Bone Level Implant Gains Approval From Ministry Of Health, Labor And Walfare In Japan 149
16.5.6 Oct 08, 2010: Straumann Introduces Straumann MembraGel For Guided Bone Regeneration In Dental Applications 149
16.5.7 Sep 01, 2010: Straumann Launches New CADCAM Dental Restoration System 150
16.5.8 May 18, 2010: Straumann Receives Frost & Sullivan Medical Device Technology Of The Year Award For Roxolid 151
16.5.9 Apr 06, 2010: Straumann To Complete Clincial Trial For Straumann Emdogain PLUS In Second Quarter Of 2010 151
16.5.10 Mar 23, 2010: Institut Straumann To Complete Comparative Study Of MembraGel In First Quarter Of 2014 151
16.5.11 Sep 25, 2009: Straumann Holding To Complete The Clinical Trial For Straumann Bonelevel Implant In First Quarter Of 2013 152
16.5.12 Sep 25, 2009: Straumann Holding To Complete The Clinical Trial For Straumann Bonelevel Implant In Fourth Quarter Of 2011 152
16.5.13 Sep 02, 2009: Straumann Holding To Complete The Clinical Trial For Straumann Bonelevel Implant In Second Half Of 2011 153
16.5.14 Oct 26, 2007: Straumann Launches New Generation Bone Level Implant In Europe And North America 153
16.6 Product Approvals 154
16.6.1 Mar 07, 2011: Straumann Bone Level Implant Gains Approval From Ministry Of Health, Labor And Walfare In Japan 154
16.7 Clinical Trials 154
16.7.1 Apr 06, 2010: Straumann To Complete Clincial Trial For Straumann Emdogain PLUS In Second Quarter Of 2010 154
16.7.2 Mar 23, 2010: Institut Straumann To Complete Comparative Study Of MembraGel In First Quarter Of 2014 154
16.7.3 Sep 25, 2009: Straumann Holding To Complete The Clinical Trial For Straumann Bonelevel Implant In Fourth Quarter Of 2011 155
16.7.4 Sep 25, 2009: Straumann Holding To Complete The Clinical Trial For Straumann Bonelevel Implant In First Quarter Of 2013 155
16.7.5 Sep 02, 2009: Straumann Holding To Complete The Clinical Trial For Straumann Bonelevel Implant In Second Half Of 2011 156
17 Appendix 157
17.1 Research Methodology 158
17.2 Secondary Research 158
17.3 Primary Research 158
17.4 Models 159
17.5 Forecasts 159
17.6 Expert Panels 159
17.7 GlobalData Consulting 159
17.8 Currency Conversion 160
17.9 Contact Us 161
17.10 Disclaimer 161


【レポート販売概要】

■ タイトル:Straumann Holding AG:市場シェア分析
■ 英文:Straumann Holding AG Market Share Analysis
■ 発行日:2013年2月28日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160562
■ 調査対象地域:グローバル
  • 鉱業ラボオートメーションソリューションの世界市場2016-2020
    About Mining Laboratory Automation Solutions The automation of laboratory functions in the mining industry reduces the requirement of human labor in the work environment, reducing human errors. Automation not only lowers errors but also improves efficiency and accuracy in most cases. Analytical instrument manufacturers have started providing complete analytical solutions instead of just instrument …
  • 2014年戦略提言:世界の薬物乱用検査市場
    Complete report $8,500.  DataPack (test volumes, sales forecasts, supplier shares) $5,500.This new 318-page report from Venture Planning Group contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.  The report provi …
  • バイオインプラントの世界市場:整形外科インプラント、心血管インプラント
    About bio-implant Bio-implant is medical device made up of biomaterials, which are used to replace, augment, or repair damaged tissues. There are two types of bio-implants: orthopedic and cardiovascular implants. The orthopedic implant includes replacement procedures for the hip, spine, knee, and other extremities such as the shoulder, wrist, elbow, and ankle. Cardiovascular bio-implants such as c …
  • アメリカの体外診断(IVD)市場:免疫測定法、臨床化学、分子診断、微生物
    The U.S. is a prime market due to the availability of government funds, expansion of molecular diagnostics for genetic disorders and cancer screening, and easy access to IVD tests through diagnostic service providers and major leading companies headquartered in the U.S. The U.S. in vitro diagnostics market is estimated to reach USD 25.99 Billion by 2020, growing at a CAGR of 4.7% during the foreca …
  • グローバル鉄道市場におけるトップ10企業分析
    This report presents key information and issues for all the leading companies in the global railway industry for business intelligence requirements. It also provides information on business operations, history, major products and services, prospects, key competitors, key employees, locations and subsidiaries for the companies featured within the report. In addition, the report also provides streng …
  • 電動推進式人工衛星の世界市場
    ABSTRACTAbout Electric Propulsion Satellite Electric-powered satellite propulsion system employs electrical energy to change the velocity of spacecraft. Most all-electric satellite propulsion systems work by electrically expelling propellant or reaction mass at high speed. The hybrid propulsion systems engage both chemical and electrical propulsion technologies. Conventional electric thrusters use …
  • Oligodendroglioma:グローバル臨床試験レビューH2, 2013
    Oligodendroglioma Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Oligodendroglioma Global Clinical Trials Review, H2, 2013" provides data on the Oligodendroglioma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Oligodendroglioma . It includes an overview of the trial numbers and their recruitment …
  • Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market
    Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market Summary GBI Research’s report “Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market” looks at the regulatory landscape and reimbursement scenario in the US for four medical device markets: cardiovascular devices, neurostimulation devices, diagnostic imaging devices and endoscopy devic …
  • 世界のタッチパネルディスプレイー市場:Global Touch Panel Display Market 2012-2016
    TechNavio's analysts forecast the Global Touch Panel Display market to grow at a CAGR of 17.7 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing adoption of smartphones and tablets. The Global Touch Panel Display market has also been witnessing the increasing preference for single glass touch panel displays. However, the high cost of glas …
  • バイオ炭の世界市場分析:技術別(熱分解、ガス化、その他)、用途別(農業(畑作、畜産、その他)、その他)、地域別、セグメント予測、2012 – 2025
    The global biochar market is expected to reach USD 3.14 billion by 2025, according to a new report by Grand View Research, Inc. Globally increasing consumption of organic food has been a major factor driving market growth. In addition, growing awareness regarding the advantages of biochar as soil amendment is further supplementing demand for the global market.Biochar is an emerging industry and th …
  • 肺がん治療ワクチンの世界市場及びパイプラインインサイト
    Lung cancer incidences are rapidly increasing and various therapeutics have been introduced in global market to provide better care to patients. Surgery and radiation therapy are not preferred for lung cancer treatment due to which they have small global market size. Chemotherapeutics and targeted therapeutics for lung cancer treatment are major market contender in global market with wide acceptan …
  • Cellulite:グローバル臨床試験レビューH1, 2013
    Cellulite Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Cellulite Global Clinical Trials Review, H1, 2013" provides data on the Cellulite clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cellulite. It includes an overview of the trial numbers and their recruitment status as per the site of trial c …
  • 化粧品用色素の世界市場予測(~2023年)
    “The cosmetic dyes market is projected to grow at a CAGR of 5.5%, in terms of value, from 2018 to 2023.” The market size of cosmetic dyes is estimated at USD 280 million in 2018 and is projected to reach USD 366 million by 2023, at a CAGR of 5.5%, from 2018 to 2023. The growth of this market is attributed to high growth of applications consuming cosmetic dyes. The increasing use of cosmetic dyes i …
  • 自動車向けアルミニウム製品の世界市場:アルミニウム鋳造、アルミニウム鍛造、アルミニウム押出、アルミニウム圧延製品
    About the Aluminum Market for Automotive Industry Aluminum is a preferred material in the automotive industry because of its strength, safety, and durability. Use of aluminum in passenger and commercial vehicles allows boosting of fuel economy and reducing vehicular emissions. The global automotive industry is driven by improvements in macroeconomic conditions and demands from the developing marke …
  • 世界の熱電対市場2015
    The Global Thermocouples Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Thermocouples industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Thermocouples market analysis is provided for the international markets including development trends, competit …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。